Patent details

Basic Information

Publication number:

EP2718315

PCT Application Number:

EP2012060899

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP127294171

PCT Publication Number:

WO2012168431

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Pramlintide derivatives

French Title of Invention:

DÉRIVÉS DE PRAMLINTIDE

German Title of Invention:

PRAMLINTIDDERIVATE

SPC Number:

Dates

Filing date:

08/06/2012

Grant date:

27/12/2017

EP Publication Date:

16/04/2014

PCT Publication Date:

13/12/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/12/2017

EP B1 Publication Date:

27/12/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/06/2018

Expiration date:

08/06/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/12/2017

 

 

Name:

Novo Nordisk A/S

Address:

Novo Allé, 2880 Bagsværd, Denmark (DK)

Inventor

1

Name:

SCHÄFFER, Lauge

Address:

Denmark (DK)

2

Name:

THØGERSEN, Henning

Address:

Denmark (DK)

3

Name:

KRUSE, Thomas

Address:

Denmark (DK)

Priority

1

Priority Number:

11169405

Priority Date:

10/06/2011

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

201161496113 P

Priority Date:

13/06/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/00; A61K 38/22; C07K 14/575; A61K 47/54;

Publication

European Patent Bulletin

Issue number:

201752

Publication date:

27/12/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/10/2018	Outgoing Correspondence	1